Bard  IVC Filter Lawsuit

Manufactured by C.R. Bard, Inc., the Bard IVC Filter come in two models: the Recovery and G-2. The devices are implanted into the inferior vena cava, which is the major vein that carries blood from the lower half of the body to the heart. The filters are designed to catch and stop blood clots before they travel to the lungs and become a pulmonary embolism. There is no particular demographic of device users although we expect that it would primarily be older people. The Bard IVC Filter could be used by anyone at high risk for developing blood clots.


The Bard IVC filter can be linked to incidents of migration, fracture, and perforation of the inferior vena cava, causing severe bleeding, removal surgery, perforation of the heart and lung, and death. In 2010 the FDA disclosed that retrievable IVC filters had been associated with more than 900 adverse events. The FDDA updated the safety communication on August 9, 2014, stating most devices should be removed between the 29th and 54th day after implantation. The original warning was May 6, 2010. Here’s a link to the 2014 warning: FDA Bard IVC Filter
According to an August 2010 study published in the Archives of Internal Medicine, the G2 failure rate is around 12%. Other studies place the Recovery failure rate as high as 25%. Industry statistics indicate that about 250,000 Americans are implanted with IVC filters each year.


On August 17, 2015, The JPML ordered the transfer of all federal lawsuits filed over allegedly a defective Bard IVC filter to the District of Arizona (MDL 2641). Lawsuits claim defective product design and failure to adequately warn. NBC News recently came out with an investigation suggesting C.R. Bard knew of the risk of perforation, yet chose not to disclose it. The NBC report states that even as death and injury reports were climbing, Bard decided not to recall the Recovery and opted to sell about 34,000 of them for nearly three years before replacing them with the G2.
The Bard Recovery hit the market in 2003 and was replaced by the G2 in 2005. The G2 is still on the market. Both devices entered the market via the FDA’s “substantial equivalent” 510(k) process.

If you or a loved one has received a Bard IVC filter in either the Recovery or G2 models and suffered an injury because of it, call us today at 704-333-0885, we can help. Our experienced legal team is here to guide you thorough these difficult times and help make things right again.